Assertio Holdings | DEPO - Cost Of Sales

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $8.89M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
J&J USD 8.07B 103M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Omeros USD 33.16M 18.52M Jun/2024
Pfizer USD 6.29B 2.12B Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025